Brightstar Associates LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:30 pm Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Brightstar Associates LLC | 23,059,708 28.200% | -48,136 (-0.21%) | Filing |
| 2023-02-08 4:16 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Brightstar Associates LLC | 23,107,844 28.200% | 6,535,474 (+39.44%) | Filing |